{
  "sources": [
    {
      "title": "Future",
      "feedUrl": "https://future.a16z.com/feed",
      "siteUrl": "https://future.com",
      "articles": [
        {
          "id": "https://future.com/?p=7114",
          "author": "Jimmy Lin and Nicole Neuman",
          "description": "Jimmy Lin is CSO of Freenome, which is developing blood-based tests for early cancer detection, starting with colon cancer. He is a pioneer in developing computational approaches to extract insights from large-scale genomic data, having spearheaded the computational analyses of the first genome-wide sequencing studies in multiple cancer types.  Lin talked to Future about the... Read More\nThe post Why Applying Machine Learning to Biology is Hard – But Worth It appeared first on Future.",
          "link": "https://future.com/why-applying-machine-learning-to-biology-is-hard-but-worth-it/",
          "publishedOn": "2022-10-05T14:00:13.000Z",
          "wordCount": 3229,
          "title": "Why Applying Machine Learning to Biology is Hard – But Worth It",
          "imageUrl": "https://future.com/wp-content/uploads/2022/10/1821-SocialShare-JimmyLin-QA-Facebook.jpg"
        }
      ]
    }
  ],
  "cliVersion": "1.15.1"
}